The Frequency of Fibromyalgia Syndrome in Patients with Polycystic Ovary Syndrome

REFERENCES

• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, : The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheum 33: 160–172, 1990.
   PubMed Web of Science ®Google Scholar
• Buskila D, Sarzi-Puttini P: Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 8: 218, 2006.
   PubMed Web of Science ®Google Scholar
• Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46: 1333–1343, 2002.
   PubMed Web of Science ®Google Scholar
• Van West D, Maes M: Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 15: 521–531, 2001.
   PubMedGoogle Scholar
• Akkuş S, Delibaş N, Tamer MN: Do sex hormones play a role in fibromyalgia? Rheumatology (Oxford) 39: 1161–1163, 2000.
   PubMedGoogle Scholar
• Dessein PH, Shipton EA, Joffe BI, Hadebe DP, Stanwix AE, Van Der Merwe BA: Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 83: 313–319, 1999.
   PubMed Web of Science ®Google Scholar
• Gur A, Cevik R, Nas K, Colpan L, Sarac S: Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 6: 232–238, 2004.
   PubMed Web of Science ®Google Scholar
• Kajantie E, Phillips DI: The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31: 151–178, 2006.
   PubMed Web of Science ®Google Scholar
• Franks S: Polycystic ovary syndrome. N Engl J Med 333(13): 853–861, 1995.
   PubMed Web of Science ®Google Scholar
• Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85: 2434–2438, 2000.
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89: 2745–2749, 2004.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 19(1): 41–47, 2004.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, : The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheum 33: 160–172, 1990.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, Moch J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 4: 561–571, 1861.
   Google Scholar
• Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 56: 893–897, 1988.
   PubMed Web of Science ®Google Scholar
• Hisli N: Validity and reliability of the Beck depression inventory in university students. J Psychol (Psikoloji Dergisi) 7: 3–13, 1989.
   Google Scholar
• Ulusoy M, Şahin NH, Erkmen H: Turkish version of the Beck anxiety inventory: Psychometric properties. J Cogn Psychother 12: 13–172, 1998.
   Google Scholar
• Rhudy JL, Williams AE: Gender differences in pain: Do emotions play a role? Gend Med 2: 208–226, 2005.
   PubMedGoogle Scholar
• Riedel W, Layka H, Neeck G: Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 57(Suppl 2): 81–87, 1998.
   PubMedGoogle Scholar
• El Maghraoui A, Tellal S, Achemlal L, Nouijai A, Ghazi M, Mounach A, : Bone turnover and hormonal perturbations in patients with fibromyalgia. Clin Exp Rheumatol 24: 428–431, 2006.
   PubMed Web of Science ®Google Scholar
• Gur A, Cevik R, Sarac AJ, Colpan L, Em S: Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: The potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis. 63: 1504–1506, 2004.
   PubMed Web of Science ®Google Scholar
• Korszun A, Young EA, Engleberg NC, Masterson L, Dawson EC, Spindler K, : Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 27: 1526–1530, 2000.
   PubMed Web of Science ®Google Scholar
• Okifuji A, Turk DC: Sex hormones and pain in regularly menstruating women with fibromyalgia syndrome. J Pain 7: 851–859, 2006.
   PubMedGoogle Scholar
• Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, : Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37: 1593–1601, 1994.
   PubMed Web of Science ®Google Scholar
• Kerdelhué B, Gordon K, Williams R, Lenoir V, Fardin V, Chevalier P, : Stimulatory effect of a specific substance P antagonist (RPR 100893) of the human NK1 receptor on the estradiol-induced LH and FSH surges in the ovariectomized cynomolgus monkey. J Neurosci Res 50(1): 94–103, 1997.
   PubMedGoogle Scholar
• Pamuk ON, Cakir N: The variation in chronic widespread pain and other symptoms in fibromyalgia patients. The effects of menses and menopause. Clin Exp Rheumatol 23: 778–782, 2005.
   PubMed Web of Science ®Google Scholar
• Häkkinen K, Pakarinen A, Hannonen P, Häkkinen A, Airaksinen O, Valkeinen H, : Effects of strength training on muscle strength, cross-sectional area, maximal electromyographic activity, and serum hormones in premenopausal women with fibromyalgia. J Rheumatol 29: 1287–1295, 2002.
   PubMed Web of Science ®Google Scholar
• Finckh A, Berner IC, Aubry-Rozier B, So AK: A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J Rheumatol 32: 1336–1340, 2005.
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, : Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88: 5801–5807, 2003.
   PubMed Web of Science ®Google Scholar
• Weiner CL, Primeau M, Ehrmann DA: Androgens and mood dysfunction in women: Comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 66: 356–362, 2004.
   PubMed Web of Science ®Google Scholar
• Himelein MJ, Thatcher SS: Depression and body image among women with polycystic ovary syndrome. J Health Psychol 11: 613–625, 2006.
   PubMed Web of Science ®Google Scholar
• Hollinrake EM, Abreu A, Sparks A: Increased risk of depression in women with polycystic ovary syndrome. Fertil Steril 87: 1369–1376, 2007.
   PubMed Web of Science ®Google Scholar
• Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, : Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 74: 299–304, 2003.
   PubMed Web of Science ®Google Scholar
• Himelein MJ, Thatcher SS: Polycystic ovary syndrome and mental health: A review. Obstet Gynecol Surv 61: 723–732, 2006.
   PubMed Web of Science ®Google Scholar
• Sule AA, Leow MK: Association of polycystic ovary syndrome and fibromyalgia in a patient with primary hyperparathyroidism: A novel triad? Clin Chem 52: 1208–1209, 2006.
   PubMedGoogle Scholar